09.12.25 -- Bristol Myers Squibb Forms Immunology Company With Finance Partner

Struggling with missing logbooks or tedious cleanroom reviews? Discover how electronic logbooks streamline compliance, boost efficiency, and unlock insights to transform operations.

Handling bulk powders presents serious challenges—from unpredictable caking to safety risks—that can disrupt workflows. Explore solutions to streamline operations and protect your team.

Understand how to confidently meet GxP compliance in the life sciences with a framework that encompasses people, processes, products, and services for regulatory adherence and data integrity.

Delve into the complexities of scaling decisions to gain insights from biopharma developers and a CDMO. Discover their shared interest in successful scale-up and strategies for avoiding common pitfalls.

Read about three tools that facilitate a successful journey from candidate compound to clinical triumph: solid form screening, PBPK modeling, and AI-enabled route scouting.

See how to build a resilient supply chain to navigate today's complex environment. Expert speakers share insights on optimization, innovation, and strategic planning to meet evolving market conditions.

Uncover highly promising in-vivo data, enabled by a nanoformed drug product for the treatment of glioblastoma multiforme (GBM).

Acquire a thorough understanding of environmental monitoring, covering the fundamentals of particle counting and cleanroom designs, regulatory expectations regarding market release, and more.

Learn how digital twins are enabling the optimization of cell culture processes for improved, more predictable outcomes in the creation of therapeutic proteins and antibodies.

How should you approach building your aseptic processing line? Gain insight into the advantages of using a modular, configurable technology rather than custom fill-finish solutions.

Aseptic processing is evolving. Regulatory changes and technological advancements are driving a shift from open cleanrooms to closed systems for sterile drug manufacturing.

Watch to reveal the essential steps to understand mixing, reduce segregation, enhance efficiency, and improve product quality with granular materials.

Despite the benefits of B/F/S over glass, some pharmaceutical companies refuse to make the switch. Find out how an investment in B/F/S may yield incredible long-term savings.